May 21, 2020 Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19. They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.…
Recent Post
- India Cracks Down on Chloramphenicol & Nitrofurans in Food Producing Animals
- CDSCO Directs All Drug Manufacturers to Establish Pharmacovigilance Systems Under Schedule M
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
